New drug shows promise for vitiligo in early trial
NCT ID NCT04338581
First seen Nov 17, 2025 · Last updated May 25, 2026 · Updated 28 times
Summary
This study tested a drug called AMG 714 in 60 adults with vitiligo, a condition that causes white patches on the skin. The goal was to see if the drug could reduce facial patches by at least 35% after 24 weeks. Participants received either the drug or a placebo, and all were asked to use light therapy. The results help researchers understand if AMG 714 is a safe and effective treatment option.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Northwell Health
Lake Success, New York, 11042, United States
-
Tufts Medical Center: Department of Dermatology
Boston, Massachusetts, 02111, United States
-
University of California Davis Health System: Department of Dermatology
Sacramento, California, 95816, United States
-
University of California, Irvine: Department of Dermatology
Irvine, California, 92697, United States
-
University of Massachusetts Medical School
Worcester, Massachusetts, 01605, United States
-
Yale University School of Medicine: Department of Dermatology
New Haven, Connecticut, 06520, United States
Conditions
Explore the condition pages connected to this study.